Skip to main content

Table 1 Baseline characteristics of the participants

From: Association of obstructive sleep apnea and diurnal variation of cystatin C

 

Simple Snoring to Mild OSA

(n = 12)

Moderate OSA

(n = 12)

Severe OSA

(n = 26)

Age, years

43.7 ± 15.8

48.5 ± 11.9

47.2 ± 12.3

Female, n (%)

2 (16.7)

4 (33.3)

3 (11.5)

BMI, kg/m2

24.9 ± 2.3

25.3 ± 3.4

29.2 ± 4.8

AHI, /hr

10.0 ± 4.6

20.9 ± 4.4

56.2 ± 23.4

ODI, /hr

5.7 ± 3.7

12.8 ± 4.0

45.7 ± 26.9

Snoring, %

29.2 ± 16.8

26.5 ± 20.4

47.7 ± 23.0

Total sleep time, min

407.9 ± 45.6

379.0 ± 50.5

350.5 ± 112.5

WASO, min

67.2 ± 36.5

82.9 ± 42.4

67.2 ± 43.8

Sleep efficiency, %

84.3 ± 8.1

77.7 ± 10.0

82.6 ± 8.6

Sleep stage N1, %

27.0 ± 14.0

23.8 ± 3.4

38.4 ± 15.5

Sleep stage N2, %

42.3 ± 7.3

41.8 ± 7.5

37.6 ± 11.2

Sleep stage N3, %

13.1 ± 10.1

12.9 ± 7.4

8.5 ± 7.3

Sleep stage REM, %

17.6 ± 5.9

21.7 ± 4.0

15.8 ± 6.5

Total arousal, /hr

24.5 ± 9.0

27.2 ± 7.6

52.1 ± 23.6

Mean O2 saturation, %

96.3 ± 1.2

96.1 ± 1.0

94.2 ± 2.8

Lowest O2 saturation, %

88.7 ± 4.1

85.3 ± 3.7

75.3 ± 1.0

Hypertension, n (%)

1 (8.3)

3 (25.0)

10 (38.5)

Diabetes mellitus, n (%)

0 (0.0)

2 (16.7)

2 (7.7)

Hyperlipidemia, n (%)

0 (0.0)

3 (25.0)

4 (15.4)

Current smoking, n (%)

1 (16.7)

4 (33.3)

7 (26.9)

  1. The kidney biomarkers were compared between the three groups. No significant differences in BUN, creatinine, or cystatin C were noted between the three groups classified by OSA severity
  2. AHI apnea–hypopnea index, BMI body mass index, ODI oxygen desaturation index, OSA obstructive sleep apnea, WASO wake after sleep onset